Boeing (BA)

Total Costs & Expenses

$24.48B

Quarterly · Period ending: · USD

BA logo

BA Total Costs & Expenses

Latest reported$24.48B
BA Quarterly Total Costs & Expenses ($3.09B → $24.48B)
High-resolution chart · PNG

BA total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boeing Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
24,482,000,000
21,769,000,000
24,763,000,000
28,064,000,000
23,017,000,000
19,035,000,000
19,065,000,000
23,601,000,000
17,956,000,000
16,655,000,000
21,735,000,000
18,912,000,000
19,850,000,000
18,070,000,000
20,333,000,000
18,748,000,000
15,901,000,000
15,153,000,000
18,964,000,000
14,949,000,000
15,975,000,000
15,300,000,000
23,353,000,000
14,540,000,000
14,771,000,000
18,261,000,000
20,115,000,000
18,721,000,000
19,131,000,000
20,567,000,000
24,166,000,000
22,919,000,000
21,548,000,000
20,507,000,000
22,338,000,000
21,593,000,000
20,521,000,000
19,755,000,000
21,103,000,000
21,616,000,000
25,174,000,000
20,844,000,000
22,412,000,000
23,269,000,000
22,860,000,000
20,130,000,000
22,443,000,000
21,665,000,000
20,258,000,000
18,923,000,000
22,270,000,000
20,327,000,000
20,099,000,000
17,365,000,000
20,673,000,000
18,449,000,000
18,463,000,000
17,818,000,000
17,958,000,000
16,013,000,000
15,009,000,000
13,910,000,000
15,447,000,000
15,580,000,000
14,266,000,000
14,042,000,000
16,244,000,000
18,839,000,000
15,625,000,000
15,477,000,000
12,907,000,000
14,146,000,000
15,715,000,000
14,191,000,000
15,961,000,000
15,018,000,000
15,522,000,000
14,056,000,000
16,389,000,000
13,788,000,000
15,034,000,000
13,305,000,000
13,660,000,000
11,592,000,000
13,866,000,000
11,994,000,000
13,286,000,000
12,641,000,000
12,444,000,000
12,079,000,000
12,516,000,000
11,758,000,000
13,029,000,000
12,628,000,000
12,662,000,000
12,128,000,000
12,582,000,000
12,829,000,000
15,457,000,000
12,621,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.